Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RayBiotech is a leading life sciences company specializing in proteomics and high-throughput protein analysis tools. The company is widely recognized for introducing the first commercially available cytokine antibody array, which revolutionized the study of cell signaling and biomarker discovery. RayBiotech provides a comprehensive suite of products and services, including ELISA kits, recombinant proteins, antibodies, and custom CRO services for pharmaceutical and academic researchers. Their technology platforms support drug discovery, clinical trials, and diagnostic development across various therapeutic areas such as oncology and immunology. Headquartered in the United States, the company serves a global market with a focus on accelerating biological research and precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raytech.